Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions.
Bertram S, Padden J, Kälsch J, Ahrens M, Pott L, Canbay A, Weber F, Fingas C, Hoffmann AC, Vietor A, Schlaak JF, Eisenacher M, Reis H, Sitek B, Baba HA.
Bertram S, et al.
J Clin Pathol. 2016 Jul;69(7):619-26. doi: 10.1136/jclinpath-2015-203418. Epub 2016 Jan 4.
J Clin Pathol. 2016.
PMID: 26729014